AAAAAA

   
Results: 1-25 | 26-31 |
Results: 26-31/31
INCLUSION-BODY MYOSITIS - PATTERN OF WEAKNESS AND CLINICAL-FEATURES AND EVIDENCE SUPPORTING THE DIAGNOSIS OF PROBABLE INCLUSION-BODY MYOSITIS
Authors: AMATO AA GRONSETH GS JACKSON CE WOLFE GI KATZ JS BRYAN WW BAROHN RJ
Citation: Aa. Amato et al., INCLUSION-BODY MYOSITIS - PATTERN OF WEAKNESS AND CLINICAL-FEATURES AND EVIDENCE SUPPORTING THE DIAGNOSIS OF PROBABLE INCLUSION-BODY MYOSITIS, Neurology, 46(2), 1996, pp. 73002-73002
TOMACULOUS NEUROPATHY - A CLINICAL AND ELECTROPHYSICAL STUDY IN PATIENTS WITH AND WITHOUT DELETIONS IN CHROMOSOME 17P11.2
Authors: AMATO AA GRONSETH GS CALLERAME KJ KAGANHALLET KS BRYAN WW BAROHN RJ
Citation: Aa. Amato et al., TOMACULOUS NEUROPATHY - A CLINICAL AND ELECTROPHYSICAL STUDY IN PATIENTS WITH AND WITHOUT DELETIONS IN CHROMOSOME 17P11.2, Neurology, 45(4), 1995, pp. 168-169
PLACEBO VERSUS NATURAL-HISTORY IN AN ALS CLINICAL-TRIAL
Authors: BRYAN WW BAROHN RJ MURPHY JR ARMON C MILLER RG GOODSPASTURE JE PARRY GJ PETAJAN J ROSS MA STROMATT S
Citation: Ww. Bryan et al., PLACEBO VERSUS NATURAL-HISTORY IN AN ALS CLINICAL-TRIAL, Neurology, 45(4), 1995, pp. 280-281
EVALUATION OF AMYOTROPHIC-LATERAL-SCLEROSIS DIAGNOSTIC-CRITERIA (ALSDC) FOR A CONTROLLED TRIAL OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF)
Authors: ROSS MA PARRY GJ MILLER RG ARMON C BAROHN R BRYAN WW PETAJAN J STROMATT S
Citation: Ma. Ross et al., EVALUATION OF AMYOTROPHIC-LATERAL-SCLEROSIS DIAGNOSTIC-CRITERIA (ALSDC) FOR A CONTROLLED TRIAL OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF), Neurology, 45(4), 1995, pp. 280-280
MRI-GUIDED BIOPSY IN INFLAMMATORY MYOPATHY - INITIAL RESULTS
Authors: PITT AM FLECKENSTEIN JL GREENLEE RG BURNS DK BRYAN WW HALLER R
Citation: Am. Pitt et al., MRI-GUIDED BIOPSY IN INFLAMMATORY MYOPATHY - INITIAL RESULTS, Magnetic resonance imaging, 11(8), 1993, pp. 1093-1099
SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: MILLER RG BRYAN WW DIETZ M MUNSAT TL PETAJAN JH SMITH SA
Citation: Rg. Miller et al., SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 34(2), 1993, pp. 304-305
Risultati: 1-25 | 26-31 |